Literature DB >> 8647135

Thermal unfolding and proteolytic susceptibility of ribonuclease A.

U Arnold1, K P Rücknagel, A Schierhorn, R Ulbrich-Hofmann.   

Abstract

With the aim to localize the structural region that becomes first accessible to proteolytic attack during thermal unfolding, the proteolysis of ribonuclease A was studied in the temperature range of 20-65 degrees C. Subtilisin, proteinase K, and elastase proved to be not appropriate as indicators of thermal unfolding, because even the native protein molecule was cleaved by these proteases. In contrast, chymotrypsin, trypsin, and thermolysin attacked ribonuclease A only after its thermal treatment. For thermolysin and trypsin, the first primary cleavage sites of ribonuclease A could be identified by blotting of the electrophoretic bands, partial N-terminal sequencing of the fragments and assignment according to their molecular masses. The results were confirmed by the separation of the proteolytic fragments by HPLC and subsequent matrix-assisted laser desorption ionization mass spectrometry. The first cleavage sites were determined to be Lys31-Ser32 and Arg33-Asn34 for trypsin and Asn34-Leu35 and Thr45-Phe46 for thermolysin. Hence the structural region from Lys31 to Leu35, together with the adjacent beta-structure containing Thr45-Phe46, is suggested to represent a labile region of the ribonuclease A molecule, which becomes exposed at thermal denaturation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8647135     DOI: 10.1111/j.1432-1033.1996.0862p.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  13 in total

1.  Differences in the denaturation behavior of ribonuclease A induced by temperature and guanidine hydrochloride.

Authors:  U Arnold; R Ulbrich-Hofmann
Journal:  J Protein Chem       Date:  2000-07

2.  Comparison of protein fragments identified by limited proteolysis and by computational cutting of proteins.

Authors:  Chung-Jung Tsai; Patrizia Polverino de Laureto; Angelo Fontana; Ruth Nussinov
Journal:  Protein Sci       Date:  2002-07       Impact factor: 6.725

3.  Use of thermolysin in the diagnosis of prion diseases.

Authors:  Jonathan P Owen; Ben C Maddison; Garry C Whitelam; Kevin C Gough
Journal:  Mol Biotechnol       Date:  2007-02       Impact factor: 2.695

4.  Selective and asymmetric action of trypsin on the dimeric forms of seminal RNase.

Authors:  C De Lorenzo; F Dal Piaz; R Piccoli; A Di Maro; P Pucci; G D'Alessio
Journal:  Protein Sci       Date:  1998-12       Impact factor: 6.725

5.  Thermal unfolding of ribonuclease A in phosphate at neutral pH: deviations from the two-state model.

Authors:  S D Stelea; P Pancoska; A S Benight; T A Keiderling
Journal:  Protein Sci       Date:  2001-05       Impact factor: 6.725

6.  Absolute quantification of prion protein (90-231) using stable isotope-labeled chymotryptic peptide standards in a LC-MRM AQUA workflow.

Authors:  Robert Sturm; Gloria Sheynkman; Clarissa Booth; Lloyd M Smith; Joel A Pedersen; Lingjun Li
Journal:  J Am Soc Mass Spectrom       Date:  2012-06-20       Impact factor: 3.109

7.  Limited proteolysis of ribonuclease A with thermolysin in trifluoroethanol.

Authors:  P Polverino de Laureto; E Scaramella; V De Filippis; M Bruix; M Rico; A Fontana
Journal:  Protein Sci       Date:  1997-04       Impact factor: 6.725

8.  Target identification using drug affinity responsive target stability (DARTS).

Authors:  Brett Lomenick; Gwanghyun Jung; James A Wohlschlegel; Jing Huang
Journal:  Curr Protoc Chem Biol       Date:  2011-12-01

9.  Replacing a single atom accelerates the folding of a protein and increases its thermostability.

Authors:  Ulrich Arnold; Ronald T Raines
Journal:  Org Biomol Chem       Date:  2016-07-12       Impact factor: 3.876

10.  Proteolytic sensitivity of a recombinant phospholipase D from cabbage: identification of loop regions and conformational changes.

Authors:  H Younus; R Schöps; A Lerchner; K P Rücknagel; A Schierhorn; M Saleemuddin; R Ulbrich-Hofmann
Journal:  J Protein Chem       Date:  2003-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.